Floatz logo

Umbralisib

Mantle Cell Lymphoma

Yazeed SawalhaSmall moleculePhase 2/3Active
CCC
48/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
40/ 100
Competitive Position
65/ 100

Competitive context

161 Active assets in the Mantle Cell Lymphoma cohort.

Asset / SponsorPhaseRating
Etoposide
Ruijin Hospital
Phase 4BBB
CIS-DIAMMINEDICHLOROPLATINUM II
National Cancer Institute (NCI)
Phase 4BBB
Vincristine sulfate
M.D. Anderson Cancer Center
Phase 2BBB
BUSULFANUM
City of Hope Medical Center
Phase 2BBB
Irinotecan
University of Michigan Rogel Cancer Center
Phase 2BBB

View all 50 →

Same molecule, other indications

Umbralisib is also rated in:

marginal zone lymphomaActive
CCC
Indicative · Phase 2/3
52 / 100
View asset →
follicular lymphomaActive
CCC
Indicative · Phase 2/3
50 / 100
View asset →
chronic lymphocytic leukemia/small lymphocytic lymphomaActive
CCC
Indicative · Phase 3
50 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →